The expression of PD-L1 was, therefore, used to understand a possible co-upregulation with a ferroptosis regulator and cysteinyl-tRNA synthetase (CARS), a described inhibitor of ferroptotic cell death shown to be highly expressed by RCC, correlating with the expression of PD-L1 and a worse prognosis and decreased overall survival, showing a possible connection between ferroptosis and the immune network orchestrated by the immune checkpoint molecules in RCC [74]. Here, CARS1 is linked to renal cell adenocarcinoma.